Literature DB >> 3140156

Paraproteinemic crystalline keratopathy.

L D Ormerod1, H B Collin, C H Dohlman, J L Craft, J F Desforges, D M Albert.   

Abstract

Paraproteinemic crystalline keratopathy is an uncommon complication of multiple myeloma and other plasma cell dyscrasias. A case of 16 years' duration was associated with an IgG kappa monoclonal gammopathy and recurrent uveitis. The corneal changes were unusually extensive and distributed throughout all corneal layers. The deposits consisted of diffuse, small, polymorphic aggregates, which were iridescent in the superficial cornea, mat elsewhere, and associated with a diffuse stromal haze; specular microscopy showed additional features. Both corneas were thickened. The deposits failed to stain histochemically, except patchily with Masson Trichrome. There was extensive immunohistochemical labeling for IgG, kappa, and surprisingly, lambda. Ultrastructurally, pleomorphic deposits were found in every corneal cell; paracrystalline deposits with internal banding were seen only in the basal epithelium. Keratocytes and endothelial cells were damaged and reduced in number. Disease recurred in a corneal graft. Three main types of paraproteinemic keratopathy can be distinguished. The deposits probably represent various metabolic products of the monoclonal protein. This is not necessarily a benign condition; hematologic control may be necessary on purely ophthalmological criteria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140156     DOI: 10.1016/s0161-6420(88)33200-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Vanishing corneal epithelial crystals following thalidomide induced resolution of myeloma related paraproteinaemia.

Authors:  G N Shuttleworth; S D Cook; J E Ropner
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

2.  A case of crystalline keratopathy in monoclonal gammopathy of undetermined significance (MGUS).

Authors:  Hyun Koo; Doo-Hwan Oh; Yeoun Sook Chun; Jae Chan Kim
Journal:  Korean J Ophthalmol       Date:  2011-05-24

Review 3.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

4.  Ophthalmic manifestations of atypical IgD multiple myeloma.

Authors:  Matthew R Edmunds; Peter Cikatricis; Subhanjan Mukherji; Jeremy D Bowyer
Journal:  BMJ Case Rep       Date:  2012-07-19

5.  [Unusual stromal corneal deposits].

Authors:  D Finis; J Stammen
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

6.  Corneal subepithelial monoclonal kappa IgG deposits in essential cryoglobulinaemia.

Authors:  I Kremer; P Wright; S Merin; J Weiss; A I Pick; H Kaufman
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

7.  The Hematologic Definition of Monoclonal Gammopathy of Undetermined Significance in Relation to Paraproteinemic Keratopathy (An American Ophthalmological Society Thesis).

Authors:  Walter Lisch; Joanna Wasielica-Poslednik; Tero Kivelä; Ursula Schlötzer-Schrehardt; Jens M Rohrbach; Walter Sekundo; Uwe Pleyer; Christina Lisch; Alexander Desuki; Heidi Rossmann; Jayne S Weiss
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 8.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

9.  Tropheryma whipplei Crystalline Keratopathy: Report of a Case and Updated Review of the Literature.

Authors:  Scott D Schoenberger; Sumeer Thinda; Stephen J Kim
Journal:  Case Rep Ophthalmol Med       Date:  2012-09-04

10.  Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects.

Authors:  Kitti Kormányos; Klaudia Kovács; Orsolya Németh; Gábor Tóth; Gábor László Sándor; Anita Csorba; Cecília Nóra Czakó; Achim Langenbucher; Zoltán Zsolt Nagy; Gergely Varga; László Gopcsa; Gábor Mikala; Nóra Szentmáry
Journal:  J Ophthalmol       Date:  2021-06-18       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.